Trading Signals: BCRX Stock Price Prediction and Forecast (Tue. Sep. 2, 2003 - Wed. Sep. 27, 2023)(BioCryst Pharmaceuticals, Inc.)
| BCRX latest price $10.0300 (-5.73%) ($10.0300 - $10.0300) on Wed. Jan. 11, 2023. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 3.67% (three month average) | RSI | 38 | Latest Price | $10.0300(-5.73%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | BCRX declines -3.2% a day on average for past five trading days. | Weekly Trend | BCRX declines -0.7% a week on average for past two weeks. | Market Behavior | Broad based rally for large cap. Broad based rally for small cap. | Correlated ETFs | Broad market will support BCRX advance at 0% a week (0% probability) XBI(33%) ARKG(32%) IBB(31%) SDY(27%) IFRA(23%) | Factors Impacting BCRX price | BCRX will decline at least -1.835% in a week (0% probabilities). VIXM(-17%) UUP(-8%) VXX(-7%) USO(-4%) EDOC(-2%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.835% (StdDev 3.67%) | Hourly BBV | -1.4 () | Intraday Trend | 0% | | | |
|
Resistance Level | $11.06 | 5 Day Moving Average | $10.97(-8.57%) | 10 Day Moving Average | $11.17(-10.21%) | 20 Day Moving Average | $11.06(-9.31%) | To recent high | -28.8% | To recent low | 0% | Market Cap | $1.77b | | | | BioCryst Pharmaceuticals, Inc. designs and develops novel, oral and small-molecule medicines. Its drug candidates include Berotralstat, BCX9930, BCX9250, RAPIVAB, ALPIVAB, RAPIACTA, PERAMIFLU, Galidesivir and Mundesine. The company was founded in 1986 and is headquartered in Durham, NC. |